
Covid-19 roundup: Swiss biotech halts inpatient PhII study; Houston-based vaccine and Chinese mRNA shot nab EUAs in Indonesia
Another Covid-19 study is hitting the breaks as a Swiss biotech is pausing its Phase II trial in patients hospitalized with Covid-19. Kinarus Therapeutics announced on Friday that the Data and Safety Monitoring Board (DSMB) […]